全文获取类型
收费全文 | 1732篇 |
免费 | 84篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 73篇 |
妇产科学 | 22篇 |
基础医学 | 181篇 |
口腔科学 | 53篇 |
临床医学 | 203篇 |
内科学 | 459篇 |
皮肤病学 | 51篇 |
神经病学 | 114篇 |
特种医学 | 338篇 |
外科学 | 114篇 |
综合类 | 26篇 |
一般理论 | 1篇 |
预防医学 | 52篇 |
眼科学 | 10篇 |
药学 | 88篇 |
中国医学 | 3篇 |
肿瘤学 | 81篇 |
出版年
2023年 | 5篇 |
2022年 | 7篇 |
2021年 | 17篇 |
2020年 | 14篇 |
2019年 | 17篇 |
2018年 | 30篇 |
2017年 | 15篇 |
2016年 | 20篇 |
2015年 | 28篇 |
2014年 | 34篇 |
2013年 | 71篇 |
2012年 | 61篇 |
2011年 | 50篇 |
2010年 | 50篇 |
2009年 | 71篇 |
2008年 | 45篇 |
2007年 | 77篇 |
2006年 | 54篇 |
2005年 | 49篇 |
2004年 | 38篇 |
2003年 | 37篇 |
2002年 | 24篇 |
2001年 | 33篇 |
2000年 | 28篇 |
1999年 | 43篇 |
1998年 | 77篇 |
1997年 | 87篇 |
1996年 | 108篇 |
1995年 | 66篇 |
1994年 | 64篇 |
1993年 | 54篇 |
1992年 | 29篇 |
1991年 | 29篇 |
1990年 | 34篇 |
1989年 | 56篇 |
1988年 | 55篇 |
1987年 | 46篇 |
1986年 | 50篇 |
1985年 | 46篇 |
1984年 | 12篇 |
1983年 | 15篇 |
1982年 | 15篇 |
1981年 | 12篇 |
1980年 | 11篇 |
1979年 | 10篇 |
1978年 | 16篇 |
1977年 | 10篇 |
1976年 | 16篇 |
1975年 | 15篇 |
1968年 | 5篇 |
排序方式: 共有1874条查询结果,搜索用时 156 毫秒
1.
2.
3.
4.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
5.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献
6.
Ongoing pregnancies after intracytoplasmic injection using cryopreserved testicular spermatozoa 总被引:4,自引:2,他引:2
Perraguin-Jayot S; Audebert A; Emperaire JC; Parneix I 《Human reproduction (Oxford, England)》1997,12(12):2706-2709
We report two clinical pregnancies occurring after intracytoplasmic sperm
injection (ICSI) using cryopreserved spermatozoa obtained from testicular
biopsy, made in two different infertility situations in our clinic. The
first patient showed a secretory azoospermia associated with elevated serum
follicular stimulating hormone (FSH) level and spermiogenesis maturation
arrest. The second patient was affected by azoospermia resulting from
bilateral epididymal obstruction. Spermatozoa present in the wet
preparation of testicular biopsy made on the day of scrotal exploration
were cryopreserved within the testicular tissue for both men.
Intracytoplasmic injections were performed at a later date, using
spermatozoa prepared from frozen-thawed tissues. In each case, three
embryos were obtained and transferred in utero. The transfers resulted in a
twin pregnancy for the first case, and in a singleton pregnancy for the
second. Living foetuses were seen in the ultrasound scan at the 7th week
and both pregnancies are proceeding to date beyond 30 weeks without
complications.
相似文献
7.
8.
9.
Pernes JM; Vitoux JF; Brenoit P; Raynaud A; Parola JL; Roth JP; Angel CY; Fiessinger JN; Roncato M; Gaux JC 《Radiology》1986,158(2):481-485
Thirty-five patients hospitalized for recent angiographically documented arterial occlusion in the legs (27 femoropopliteal arteries and eight grafts) benefited from local fibrinolytic therapy delivered at the site of the occlusion with a 4- or 5-F catheter. This therapy combined a continuous urokinase (UK) infusion of 1,000 U/kg/hour and a lysyl plasminogen (LYS-PLG) infusion of 15 microkatals every 30 minutes. Angiographically confirmed lysis was obtained in 85% of the cases. Only 3% of the patients had major and 6% had minor groin hematomas. Only two patients had concentrations of fibrinogen as low as 100 mg/dl. Intravascular infusion of UK-LYS-PLG is as effective as streptokinase. Its excellent tolerance makes it a good alternative in the treatment of acute ischemia in the lower limbs. 相似文献
10.
F. M. Ulivieri L. P. Piodi G. Marotta D. Marchelli C. Commadini L. Parravicini C. Verdoia P. Gerundini 《Journal of orthopaedics and traumatology》2006,7(4):192-194
Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of
serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients
(4 men) affected by active Paget’s disease of bone (6 polyostotic, 3 monostotic) not responsive to clodronate were studied.
Serum OPG, osteocalcin, total and bone isoenzyme of alkaline phosphatase (AP and BAP, respectively), and urinary deoxypyridinoline
(DPD) were measured before and 5 months after neridronate treatment (100 mg/day, i.v. for two days). A scintigraphic activity
index (SAI) was also calculated before treatment. Mean baseline OPG levels were within normal values and were not significantly
different 5 months after neridronate treatment. In contrast, there were significant reductions in AP (41.9%, p<0.02) and BAP (38.8%, p<0.04). Serum OPG levels correlated with DPD (r=0.925) and SAI (r=0.689). Although OPG is an important regulator of bone metabolism,
in our series of already treated patients it was not a sensitive marker for diagnosing Paget's disease and for monitoring
the response to pharmacological treatment, whereas AP and BAP confirmed their clinical usefulness. This preliminary study
requires confirmation by a study with a larger population. 相似文献